| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553822 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene |
| 06/30/2009 | US7553821 Methods for selectively modulating survivin apoptosis pathways |
| 06/30/2009 | US7553811 administering a CD200 fusion protein; tranplant rejection, fetal loss, autoimmune disease, and allergies; immunosuppresant |
| 06/30/2009 | US7553641 Tumour necrosis factor binding ligands |
| 06/30/2009 | US7553631 RBP4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 06/30/2009 | CA2359318C Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 06/30/2009 | CA2222453C Therapeutic and drug screening methods for the treatment and prevention of neuronal disease |
| 06/30/2009 | CA2211118C Stable lipid-comprising drug delivery complexes and methods for their production |
| 06/25/2009 | WO2009079451A2 Compositions and methods of promoting wound healing |
| 06/25/2009 | WO2009079407A2 Apparatuses, methods, and systems for a code-mediated content delivery platform |
| 06/25/2009 | WO2009077995A1 Cosmetic use of acid ceramidase type proteins |
| 06/25/2009 | WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's |
| 06/25/2009 | WO2009076775A1 Immune response modulation and uses thereof |
| 06/25/2009 | WO2009009591A9 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 06/25/2009 | WO2008142479A3 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 06/25/2009 | US20090163702 siRNA targeting Myeloid cell leukemia sequence 1 |
| 06/25/2009 | US20090163701 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090163436 Methods for delivery of nucleic acids |
| 06/25/2009 | US20090163434 miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/25/2009 | US20090162338 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) |
| 06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 06/25/2009 | US20090162320 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 06/25/2009 | CA2709398A1 Compositions and methods of promoting wound healing |
| 06/25/2009 | CA2707309A1 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it |
| 06/24/2009 | EP1011733B1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 06/24/2009 | EP0935664B1 New systems for regulating genetic expression |
| 06/23/2009 | US7551271 Uncaging devices |
| 06/23/2009 | US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 06/23/2009 | US7550580 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 06/23/2009 | US7550512 Polyethylene glycol containing sugar residue and carboxylic acid side chains; drug delivery and gene transfer carrier; aggregation inhibition; expression efficiency; water solubility |
| 06/23/2009 | US7550441 Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
| 06/23/2009 | US7550285 Endotoxin binding lactic acid bacteria and bifidobacteria |
| 06/23/2009 | US7550148 Contacting the target cell with a recombinant HSV particle comprising an altered gD forming a fusion with a peptide ligand to a receptor specific to the cell wherein the altered gD exhibits reduced binding to at least one of the cellular receptors of wild type gD; cell imaging; gene therapy; kits |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | CA2373466C Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh) |
| 06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
| 06/23/2009 | CA2251696C Genetic suppression and replacement |
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 06/18/2009 | WO2009076580A2 Compositions and methods for the treatment and prevention of cardiovascular diseases |
| 06/18/2009 | WO2009075882A2 Impaired wound healing compositions and treatments |
| 06/18/2009 | WO2009075815A1 Immunomodulating gene therapy |
| 06/18/2009 | WO2009075787A1 Compositions and methods of treating neoplasia |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075344A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| 06/18/2009 | WO2009075329A1 Gelatin composition with controlled degradability |
| 06/18/2009 | WO2009074990A2 Rtp801l sirna compounds and methods of use thereof |
| 06/18/2009 | WO2009074707A1 Grk2 antitumour therapy |
| 06/18/2009 | WO2009074076A1 A complex molecule interfering the expression of target genes and its preparing methods |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | WO2008140961A3 Papillomavirus pseudoviruses for detection and therapy of tumors |
| 06/18/2009 | WO2007059303A3 Compositions for coordinated vegf and pdgf expression, and methods of use |
| 06/18/2009 | WO2007056560A3 System and method for cytological analysis by raman spectroscopic imaging |
| 06/18/2009 | WO2005084366A3 Transcription factor rna interference reagents and methods of use thereof |
| 06/18/2009 | WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/18/2009 | WO2004055156A3 A vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis |
| 06/18/2009 | WO2004024082A3 Highly specific modulators of gtpases for target validation |
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 06/18/2009 | WO2003072756A3 Cloning and characterization of slc26a8 and slc26a11 anion exchangers |
| 06/18/2009 | US20090156796 Metastatic colon cancer specific promoter and uses thereof |
| 06/18/2009 | US20090156794 Compositions and methods for activating genes of interest |
| 06/18/2009 | US20090156543 Methods and compositions relating to expression factors |
| 06/18/2009 | US20090156539 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field |
| 06/18/2009 | US20090156528 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/18/2009 | US20090156527 Antiviral oligonucleotides targeting viral families |
| 06/18/2009 | US20090156519 Modified KSA and Uses Thereof |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155904 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 06/18/2009 | US20090155789 Genes from the 20q13 amplicon and their uses |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155268 Growth Factor Binding Constructs Materials and Methods |
| 06/18/2009 | US20090155233 Method for treating tumor using irradiated tumor cell expressing human hepatitis b surface antigen and a pharmaceutical composition comprising the tumor cell |
| 06/18/2009 | US20090155232 Neonatal human hepatocytes immortalized using tert and methods of their use |
| 06/18/2009 | US20090155231 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery |
| 06/18/2009 | US20090155230 Novel genes and markers in essential arterial hypertension |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | CA2709153A1 Impaired wound healing compositions and treatments |
| 06/18/2009 | CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
| 06/17/2009 | EP2071030A2 Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus |
| 06/17/2009 | EP2070939A1 Modulators of pharmacological agents |
| 06/17/2009 | EP2070546A1 Preventives/remedies for cancer |
| 06/17/2009 | EP2069398A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 06/17/2009 | EP2068937A2 Polymer-stabilized liposomal compositions and methods of use |
| 06/17/2009 | EP2068830A2 Modified two-component gelation systems for the treatment of post-myocardial infarction |